Vincent Calvez Selected Research

Didanosine (Videx)

2/2007	Phenotypic susceptibility to didanosine is associated with antiviral activity in treatment-experienced patients with HIV-1 infection.
3/2005	Didanosine in HIV-1-infected patients experiencing failure of antiretroviral therapy: a randomized placebo-controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vincent Calvez Research Topics

Disease

11	Infections 10/2020 - 05/2002
8	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2022 - 03/2002
8	COVID-19 01/2022 - 01/2020
8	Viremia 10/2021 - 12/2002
7	HIV Infections (HIV Infection) 01/2017 - 01/2006
4	Inflammation (Inflammations) 05/2022 - 11/2009
4	Neoplasms (Cancer) 12/2021 - 09/2012
4	Acquired Immunodeficiency Syndrome (AIDS) 01/2019 - 12/2015
3	Acne Vulgaris 05/2022 - 11/2009
3	Encephalitis (Encephalitis, Rasmussen) 01/2017 - 09/2010
3	Disease Progression 08/2015 - 10/2002
3	Hepatitis B 01/2006 - 01/2002
2	Primary Effusion Lymphoma 01/2022 - 10/2007
2	Persistent Infection 12/2021 - 05/2002
2	Pneumonia (Pneumonitis) 01/2021 - 01/2020
2	Castleman Disease (Castleman's Disease) 10/2007 - 10/2003
2	Lipodystrophy 01/2007 - 12/2002
1	Common Cold 01/2022
1	Hepatitis 01/2018
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2018
1	Glioma (Gliomas) 09/2012
1	Necrosis 01/2012
1	Lithiasis 01/2012
1	Fanconi Syndrome (Syndrome, Fanconi) 02/2007
1	Diarrhea 03/2005
1	Hodgkin Disease (Hodgkin's Disease) 09/2004
1	AIDS-Related Lymphoma (Lymphoma, AIDS Related) 09/2004
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2004
1	Opportunistic Infections (Opportunistic Infection) 12/2002

Drug/Important Bio-Agent (IBA)

9	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 02/2004
4	RNA (Ribonucleic Acid)IBA 12/2015 - 09/2010
3	Antiviral Agents (Antivirals)IBA 10/2019 - 02/2007
3	Pharmaceutical PreparationsIBA 01/2017 - 12/2002
2	AntigensIBA 01/2022 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 12/2021 - 12/2002
2	Rituximab (Mabthera)FDA Link 10/2021 - 10/2003
2	Ritonavir (Norvir)FDA Link 01/2021 - 05/2003
2	dolutegravirIBA 01/2018 - 09/2014
2	Viral RNAIBA 01/2017 - 01/2012
2	Atazanavir Sulfate (Reyataz)FDA Link 01/2017 - 01/2012
2	Tenofovir (Viread)FDA Link 01/2011 - 02/2007
2	Didanosine (Videx)FDA LinkGeneric 02/2007 - 03/2005
2	Reverse Transcriptase InhibitorsIBA 01/2007 - 05/2003
2	NucleosidesIBA 01/2007 - 05/2003
2	adefovir dipivoxil (Hepsera)FDA Link 01/2006 - 05/2002
2	Lamivudine (Epivir)FDA Link 01/2006 - 05/2002
1	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2022
1	Peptides (Polypeptides)IBA 05/2022
1	Meclizine (Meclozine)FDA LinkGeneric 04/2022
1	Primaquine FDA Link 01/2022
1	Viral AntigensIBA 01/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022
1	AntibodiesIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Immunoglobulin M (IgM)IBA 01/2022
1	CyclinsIBA 12/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2021
1	remdesivirIBA 10/2021
1	RNA-Dependent RNA Polymerase (RNA Dependent RNA Polymerase)IBA 10/2021
1	Lopinavir FDA Link 01/2021
1	XAV-19IBA 01/2021
1	Raltegravir Potassium FDA Link 01/2020
1	Virulence Factors (Pathogenicity Factors)IBA 01/2020
1	HDL CholesterolIBA 01/2020
1	CholesterolIBA 01/2020
1	etravirine (TMC-125)FDA Link 01/2020
1	IntegrasesIBA 01/2018
1	Rilpivirine (TMC-278)IBA 01/2018
1	Immunosuppressive Agents (Immunosuppressants)IBA 03/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2013
1	Procarbazine (Matulane)FDA Link 09/2012
1	Temozolomide (Temodar)FDA LinkGeneric 09/2012
1	Vincristine (Oncovin)FDA LinkGeneric 09/2012
1	Membrane Proteins (Integral Membrane Proteins)IBA 09/2012
1	Lipopolysaccharide ReceptorsIBA 01/2012
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2012
1	C-Reactive ProteinIBA 01/2012
1	Interleukin-8 (Interleukin 8)IBA 01/2012
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2012
1	Nevirapine (Viramune)FDA Link 01/2011
1	efavirenz (Sustiva)FDA Link 01/2011
1	Emtricitabine (Emtriva)FDA Link 01/2011
1	Niacinamide (Nicotinamide)FDA LinkGeneric 11/2009
1	Mitochondrial DNA (mtDNA)IBA 01/2007
1	Foscarnet FDA LinkGeneric 01/2006
1	Indinavir (Crixivan)FDA Link 05/2003
1	VaccinesIBA 12/2002
1	HIV AntigensIBA 12/2002
1	Human immunodeficiency virus 1 reverse transcriptaseIBA 05/2002
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 05/2002

Therapy/Procedure

13	Therapeutics 01/2022 - 12/2002
4	Highly Active Antiretroviral Therapy (HAART) 09/2004 - 03/2002
2	Drug Therapy (Chemotherapy) 09/2012 - 09/2004
1	Art Therapy 01/2016
1	Radiotherapy 09/2012
1	Duration of Therapy 04/2010
1	Hematopoietic Stem Cell Transplantation 09/2004
1	Liver Transplantation 02/2004
1	Transplantation 06/2002